ArticleJournal of sickle cell disease2025
Inpatient and emergency healthcare utilization and payments for care of SCD: an analysis of all payers in Florida 2010-2019.
Article in Journal of sickle cell disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Gene therapy offers transformative treatment for SCD, but access limitations necessitate continued reliance on traditional care, especially among pediatric and underserved populations. Thus, understanding healthcare utilization patterns and costs remains necessary for ongoing management and policy planning. We analyze all-payer emergency department (ED) and inpatient hospitalization data for Florida patients with SCD from 2010 to 2019. Payment estimates are constructed using novel charge-to-payment conversion methods. Outcomes are stratified by age (pediatric <12 years, adolescents 12-20 years, adults >20 years), insurance status, and income quartile. We find that ED visits for SCD increased by 95.7%, with the greatest growth among adults (106.3%). Mean ED payments rose across all age groups. Adult visits generated the highest average payments. Inpatient admissions grew by 13%, driven exclusively by adults. Mean inpatient length of stay (LOS) decreased across all age groups. SES analysis reveals persistent disparities, with the majority of ED visits and hospitalizations occurring in lower-income communities and among Medicaid (the payer with the lowest reimbursement rates) recipients. Our findings suggest that adults are increasingly the most resource-intensive users of healthcare, as successes in treatments have shifted the burden of care from children to adults. Shifts in health care resources have not appeared, however, to have kept pace with the changing demographics of the population with SCD (pediatric to adult care). ED use may have escalated particularly among adults because of the reduced access to prescription opioids for pain management in 2018 and lack of healthcare resources for non-pediatric SCD populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.